SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-041370
Filing Date
2024-05-09
Accepted
2024-05-09 17:06:38
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205500-s3_cormedix.htm S-3 496863
2 SALES AGREEMENT WITH LEERINK PARTNERS LLC DATED MAY 9, 2024 ea020550001ex1-2_cormedix.htm EX-1.2 245046
3 OPINION OF WILLKIE FARR AND GALLAGHER LLP ea020550001ex5-1_cormedix.htm EX-5.1 24707
4 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED ACCOUNTING FIRM ea020550001ex23-1_cormedix.htm EX-23.1 2117
5 FILING FEE TABLE ea020550001ex-fee_cormedix.htm EX-FILING FEES 147243
6 GRAPHIC image_001.jpg GRAPHIC 10040
7 GRAPHIC ex5-1_001.jpg GRAPHIC 4115
  Complete submission text file 0001213900-24-041370.txt   936784
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279277 | Film No.: 24931779
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)